Tecan Group AG (FRA:TEN)

Market Cap	1.81B
Revenue (ttm)	970.69M
Net Income (ttm)	67.59M
Shares Out	n/a
EPS (ttm)	5.30
PE Ratio	26.82
Forward PE	19.74
Dividend	3.00 (2.04%)
Ex-Dividend Date	Apr 14, 2025

Volume	n/a
Average Volume	2
Open	146.10
Previous Close	145.70
Day's Range	144.80 - 146.10
52-Week Range	140.50 - 188.60
Beta	n/a
RSI	42.77
Earnings Date	Mar 16, 2026

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Commercial Physical and Biological Research
• Founded: 1980
• Employees: 3,341
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TEN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF